Josef Scheiber

发表

Chemogenomic analysis of safety profiling data.

Jeremy L Jenkins, Josef Scheiber, J. Jenkins, 2009, Methods in molecular biology.

How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space

Andreas Bender, Meir Glick, Jeremy L. Jenkins, 2009, J. Chem. Inf. Model..

Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data

Andreas Bender, Meir Glick, Jeremy L. Jenkins, 2007, J. Chem. Inf. Model..

Side effect profile prediction – Tackling Big Pharma’s worst nightmare at an early stage

Josef Scheiber, 2007 .

Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis

Bin Chen, Andreas Bender, Meir Glick, 2009, J. Chem. Inf. Model..

Comparison of Cyclodextrin‐Dipeptide Inclusion Complexes in the Absence and Presence of Urea by Means of Capillary Electrophoresis, Nuclear Magnetic Resonance and Molecular Modeling

Knut Baumann, Ulrike Holzgrabe, Josef Scheiber, 2007 .

"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hits.

Andreas Bender, Meir Glick, Mariusz Milik, 2008, Journal of medicinal chemistry.

Knowledge‐Based and Computational Approaches to In Vitro Safety Pharmacology

Andreas Bender, Jeremy L. Jenkins, Kamal Azzaoui, 2009 .

Plate-Based Diversity Selection Based on Empirical HTS Data to Enhance the Number of Hits and Their Chemical Diversity

Andreas Bender, Meir Glick, Dmitri Mikhailov, 2009, Journal of biomolecular screening.

Targeting acetylcholinesterase to treat neurodegeneration

Vildan Alptüzün, Ulrike Holzgrabe, Josef Scheiber, 2007, Expert opinion on therapeutic targets.

How can we enable drug discovery informatics for personalized healthcare?

Josef Scheiber, J. Scheiber, 2011, Expert opinion on drug discovery.